Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Angew Chem Int Ed Engl ; 55(32): 9277-81, 2016 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-27364983

RESUMEN

The fusion of the sp(3) -hybridized parent diamondoid adamantane with the sp(2) -hybridized pyrene results in a hybrid structure with a very large dipole moment which arises from bending the pyrene moiety. Presented herein is the synthesis, study of the electronic and optical properties, as well as the dynamic behavior of this new hydrocarbon.

2.
J Biochem ; 141(4): 503-11, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17308344

RESUMEN

Endothelial progenitor cells (EPCs) play a role in endogenous neovascularization of ischaemic tissues. Isolation and characterization of EPCs from circulating mononuclear cells are important for developing targeted cellular therapies and reproducibility of data are the major scientific goals. Here we compared two currently employed isolation methods, i.e. from total peripheral blood mononuclear cells (PBMCs) and from enriched CD133(+) cells, by defining the cell morphology and functional activities. We show that EPCs from cultured PBMCs resulted in an adherent population of 23% +/- 4% merged cells positive for Dil-Ac-LDL and lectin, whereas the percentage of double positive cells in cultured CD133(+) enriched cells was 50% +/- 7% (P < 0.01). These data were obtained through a novel and a more complete method of analysis of cell calculations (specifically by dividing each microscope field into 120 subfields). When stimulated with tumour necrosis factor alpha (TNF)-alpha and glucose, cell number was reduced in EPCs from total PBMCs and, more consistently, in CD133(+) enriched cells. However, both cultured total PBMCs and CD133(+) enriched cells respond similarly to TNF-alpha or glucose-induced p38-phosphorylation. EPCs from both procedures show similar results in terms of phenotype and response to modulators of their functional activities. However, when the cell phenotype of CD133(+) enrichment-derived cells was compared with that of cells from the total PBMC, a significant increase in CD133(+) expression was observed (P < 0.01) This may have relevance during intervention studies using cultured EPCs.


Asunto(s)
Antígenos CD/metabolismo , Separación Celular/métodos , Células Endoteliales/citología , Glicoproteínas/metabolismo , Células Madre Hematopoyéticas/citología , Péptidos/metabolismo , Antígeno AC133 , Células Cultivadas , Células Endoteliales/metabolismo , Glucosa/metabolismo , Humanos , Leucocitos Mononucleares/citología , Fenotipo , Factor de Necrosis Tumoral alfa/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
3.
FASEB J ; 20(7): 1015-7, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16571775

RESUMEN

The transacetylase (TA), reported to be identical to platelet-activating factor (PAF) acetylhydrolase (II), is a multifunctional enzyme with three catalytic activities: lysophospholipid transacetylase (TA(L)), sphingosine transacetylase (TA(S)), and acetylhydrolase (AH). We report that TA(L) activity participates in the control of PAF levels in monocytes and macrophages and that its regulation differs in these two types of cells. In monocytes, LPS or granulocyte-macrophage colony-stimulating factor (GM-CSF) specifically increased the TA(L) activity. Western blot analysis and enzyme assays on immunoprecipitates revealed that the increased activity can be ascribed to PAF-AH (II) and that both translocation from cytosol to membranes and p38/ERKs-mediated phosphorylation regulate the enzyme activation. Instead, in macrophages differentiated in vitro from monocytes by incubation with FCS, an increase of both TA(L) and AH activities was observed. Moreover, activation of ERKs and p38 MAP kinase was not required for the up-regulation of PAF-AH (II) in differentiated macrophages. The differences observed in macrophages as compared to monocytes can be explained by 1) p38/ERKs-independent phosphorylation of PAF-AH (II) and 2) appearance of plasma PAF-AH in the course of macrophage differentiation.


Asunto(s)
1-Acilglicerofosfocolina O-Aciltransferasa/metabolismo , Macrófagos/metabolismo , Monocitos/metabolismo , Factor de Activación Plaquetaria/metabolismo , 1-Alquil-2-acetilglicerofosfocolina Esterasa/metabolismo , Membrana Celular/metabolismo , Citosol/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Humanos , Isoenzimas , Lipopolisacáridos/farmacología , Macrófagos/enzimología , Monocitos/enzimología , Transporte de Proteínas , Factores de Tiempo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
4.
Chem Sci ; 8(1): 405-410, 2017 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-28451185

RESUMEN

The structure and dynamics of enigmatic hexa(3,5-di-tert-butylphenyl)ethane was characterized via NMR spectroscopy for the first time. Our variable temperature NMR analysis demonstrates an enthalpy-entropy compensation that results in a vanishingly low dissociation energy (ΔG298d = -1.60(6) kcal mol-1). An in silico study of increasingly larger all-meta alkyl substituted hexaphenylethane derivatives (Me, iPr, t Bu, Cy, 1-Ad) reveals a non-intuitive correlation between increased dimer stability with increasing steric crowding. This stabilization originates from London dispersion as expressed through the increasing polarizability of the alkyl substituents. Substitution with conformationally flexible hydrocarbon moieties, e.g., cyclohexyl, introduces large unfavourable entropy contributions. Therefore, using rigid alkyl groups like tert-butyl or adamantyl as dispersion energy donors (DED) is essential to help stabilize extraordinary bonding situations.

5.
Biochem Pharmacol ; 71(10): 1479-87, 2006 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-16580641

RESUMEN

Yuccaols (A, B, C) are phenolic constituents isolated from Yucca schidigera bark characterized by unusual spirostructures made up of a C15 unit and a stilbenic portion closely related to resveratrol. These novel compounds are of particular interest for their antioxidant and anti-inflammatory properties. However, their effects on cell proliferation, migration, and platelet-activating factor (PAF) biosynthesis remain unknown. PAF, a potent mediator of inflammation, is known to promote angiogenesis and in vitro migration of endothelial cells and Kaposi's sarcoma (KS) cells. The objective of our study was to determine the effect of Yuccaols and resveratrol on the vascular endothelial growth factor (VEGF)-induced proliferation, migration, and PAF biosynthesis in KS cells. The results indicated that Yuccaols (25 microM) were more effective than resveratrol (25 microM) in inhibiting the VEGF-induced KS cell proliferation. Western blot analysis revealed that Yuccaols reduced the VEGF-induced phosphorylation of p38 and p42/44, thus indicating a possible interference with the mechanism underlying the VEGF-stimulated cell proliferation. Furthermore, Yuccaols completely inhibited the VEGF-stimulated PAF biosynthesis catalyzed by the acetyl-CoA:lyso-PAF acetyltransferase and enhanced its degradation through the PAF-dependent CoA-independent transacetylase (250% of control). In addition, Yuccaol C abrogated the PAF-induced cell motility whereas Yuccaol A and Yuccaol B reduced the cell migration from 7.6 microm/h to 6.1 microm/h and 5.6 microm/h, respectively. These results indicate that the anti-inflammatory properties attributed to Yucca schidigera can be ascribed to both resveratrol and Yuccaols and provide the first evidences of the anti-tumor and anti-invasive properties of these novel phenolic compounds.


Asunto(s)
Antineoplásicos/farmacología , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Factor de Activación Plaquetaria/biosíntesis , Sarcoma de Kaposi/tratamiento farmacológico , Compuestos de Espiro/farmacología , Yucca/química , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Fosforilación/efectos de los fármacos , Corteza de la Planta/química , Extractos Vegetales/química , Extractos Vegetales/farmacología , Resveratrol , Sarcoma de Kaposi/metabolismo , Sarcoma de Kaposi/patología , Estilbenos/farmacología , Células Tumorales Cultivadas , Factor A de Crecimiento Endotelial Vascular/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
6.
Steroids ; 70(9): 594-603, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15946718

RESUMEN

Seven new 15-keto pregnane glycosides, namely Stemmosides E--K, were isolated from Solenostemma argel. Stemmosides E--J are characterized by the occurrence of an uncommon 14 beta proton configuration while stemmosides E and F possess in addition a rare enolic function in C-16. On the other hand, stemmosides G-J display an unusual C-17 alpha side chain. Their structures were established by ESI-MS and NMR experiments. Moreover, the effect of these compounds on the VEGF-induced in Kaposi's sarcoma cell proliferation was tested. Results indicated that all the compounds reduced the cell proliferation in a dose dependent manner.


Asunto(s)
Apocynaceae/química , Proliferación Celular/efectos de los fármacos , Glicósidos/química , Pregnanos/química , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/aislamiento & purificación , Antineoplásicos Fitogénicos/farmacología , Línea Celular Tumoral , Glicósidos/aislamiento & purificación , Glicósidos/farmacología , Humanos , Espectroscopía de Resonancia Magnética , Estructura Molecular , Extractos Vegetales/química , Pregnanos/aislamiento & purificación , Pregnanos/farmacología , Espectrometría de Masa por Ionización de Electrospray , Factor A de Crecimiento Endotelial Vascular/farmacología
7.
Lipids ; 37(11): 1047-52, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12558054

RESUMEN

Release of FFA from membrane phospholipids was observed after incubation of umbilical cord vein-derived endothelial cells (HUVEC) with vascular endothelial growth factor (VEGF). In particular, we found an increase of arachidonate, stearate, and palmitate in a time-dependent manner with a peak at 30 min. The maximum increase was reached by arachidonate (4.4-fold), followed by stearate (2.2-fold) and palmitate (1.3-fold). The arachidonate increase can be ascribed to the activation of phospholipase A2 (PLA2). In fact, cells preincubated with arachidonyl trifluoromethyl ketone, a PLA2 inhibitor, showed a marked reduction in arachidonate mobilization. The role of Ca2+ in PLA2 activation was also investigated. Cells incubated with VEGF in the presence of EGTA showed a marked decrease in arachidonate mobilization, whereas incubation with the calcium ionophore A23187 alone produced an increase in arachidonate, although to a lesser extent compared with the VEGF stimulation. Incubation with A23187 in association with PMA produced the same increase in arachidonate as the VEGF treatment. Mitogen-activated protein kinase (MAPK) activity was also found to increase as a consequence of VEGF stimulation. Taken together, these results suggest that the VEGF-mediated activation of PLA2 in HUVEC is dependent on both MAPK-mediated phosphorylation and Ca2+ increase. Furthermore, the increase in stearate and palmitate likely is brought about by the activation of a pathway involving phospholipase D, phosphatidate phosphohydrolase (PAP), and DAG lipase. In fact, the increase in those FFA was prevented when HUVEC were stimulated with VEGF in the presence of ethanol (which inhibits the formation of phosphatidate), propranolol (a specific inhibitor of PAP), or RHC-80267 (a specific inhibitor of DAG lipase).


Asunto(s)
Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Ácidos Grasos/metabolismo , Factores de Crecimiento Endotelial Vascular/farmacología , Ácido Araquidónico/metabolismo , Células Cultivadas , Endotelio Vascular/citología , Ácidos Grasos no Esterificados/metabolismo , Humanos , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Fosfolipasa D/metabolismo , Fosfolipasas A/metabolismo , Fosfolipasas A2 , Venas Umbilicales/citología , Venas Umbilicales/efectos de los fármacos , Venas Umbilicales/metabolismo
8.
Am J Pathol ; 166(5): 1515-22, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15855650

RESUMEN

In the present study, we evaluated whether motility of Kaposi's sarcoma (KS) cells induced by platelet-activating factor (PAF) is dependent on the regulation of adherens junctions components. The results obtained indicate that PAF dose and time dependently reduced the endogenous expression of the main components of the adherens junctions: VE-cadherin, alpha-catenin, and beta-catenin. In addition, PAF initiated events that directly or indirectly up-regulated both the tyrosine and serine/threonine phosphorylation pathways, and both types of phosphorylation of beta-catenin were involved in the motility of KS cells. This motility was abrogated by addition of the tyrosine kinase inhibitor genistein, suggesting that this phosphorylation is an important signal responsible for breaking down the adherens junctions and diminishing the ability of neighboring cells to interact. Furthermore, immunofluorescence analysis showed that beta-catenin and VE-cadherin staining changed from a uniform distribution along the membrane of controls to a diffuse pattern with gap formation in PAF-treated KS cells. In conclusion, the data presented here indicate that PAF induces tumor cell motility by altering cell-cell adhesion through beta-catenin phosphorylation.


Asunto(s)
Cadherinas/metabolismo , Proteínas del Citoesqueleto/metabolismo , Factor de Activación Plaquetaria/farmacología , Sarcoma de Kaposi/fisiopatología , Transactivadores/metabolismo , Antígenos CD , Adhesión Celular/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Humanos , Fosforilación/efectos de los fármacos , Sarcoma de Kaposi/metabolismo , Sarcoma de Kaposi/patología , Distribución Tisular , Ubiquitina/metabolismo , alfa Catenina , beta Catenina
9.
J Lipid Res ; 44(2): 380-7, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12576520

RESUMEN

PAF-dependent transacetylase (TA) modifies the functions of platelet-activating factor (PAF), a potent inflammatory lipid, either by transferring the acetyl group from PAF to lysophospholipids (TAL activity), or to sphingosine (TAS activity) or by hydrolyzing PAF (acetylhydrolase activity). In stimulated endothelial cells (EC), TAL activity contributes to the synthesis of acyl-PAF, an acyl analog of PAF, that antagonizes PAF functions and is regulated by the cellular redox state. In this study, we investigated the possible involvement of TA in the flavonoid antioxidant mechanism(s) during oxidative stress in EC induced by hydrogen peroxide. The treatment of EC with H2O2 resulted in 4-fold increase of the acetyl-CoA acetyltransferase activity (AT), that is responsible for PAF biosynthesis, while the TAL activity increased only by 53%. However, the preincubation of H2O2-treated EC with the flavonoids hesperedin, naringin, and quercetin strongly inhibited AT activity and activated TAL by 290%, 340%, and 250%, respectively. The induction of TAL activity resulted in enhanced biosynthesis of 1-acyl-2-[3H]acetyl-PAF in intact EC and was related to the flavonoid structure. These findings suggest that TAL is involved in the flavonoid anti-inflammatory action by enhancing the production of acyl-PAF.


Asunto(s)
Acetiltransferasas/metabolismo , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Flavonoides/metabolismo , Estrés Oxidativo , Fosfolípidos/metabolismo , Factor de Activación Plaquetaria/metabolismo , Animales , Bovinos , Células Cultivadas , Activación Enzimática , Flavonoides/química , Peróxido de Hidrógeno/metabolismo , Oxidantes/metabolismo , Oxidación-Reducción
10.
Carcinogenesis ; 24(3): 535-40, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12663515

RESUMEN

Styrene-7,8-oxide (SO), the major in vivo metabolite of styrene, one of the most important plastic monomers worldwide, is classified as carcinogenic in humans and animals. Although the toxic effects of SO have been extensively documented in human lymphocytes, the molecular mechanisms responsible for SO-induced cell damage are still unknown. In the present study, we evaluated the effect of SO on growth and apoptosis, assessed by FACS and gel ladder analysis, in neuronal PC12 cell line. Our results demonstrate that SO triggered PC12 cell apoptosis in a dose- and time-dependent manner. PC12 apoptosis was associated with caspase-3 activation and modulation of the Bcl-2 family proteins. In addition, examination of the cytoskeleton showed that SO induced F-actin depolymerization and a rapid cell rounding before caspase-3 activation, suggesting that the changes in cell shape involving cytoskeletal structure are an early step in the apoptotic pathway. Therefore, SO triggers a complex apoptotic response consisting of a loss of cytoskeletal organization that precedes caspase-3 activation. These mechanisms may represent the molecular basis of the different SO sensitivity to tumor promotion among species and organs.


Asunto(s)
Apoptosis/efectos de los fármacos , Compuestos Epoxi/farmacología , Neuronas/efectos de los fármacos , Animales , Western Blotting , Caspasa 3 , Caspasas/metabolismo , Activación Enzimática , Neuronas/citología , Células PC12 , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA